Loading...
Announcement Date | Role | Value |
---|---|---|
October 2025 |
Exclusive Financial Advisor to Inspire11, a Portfolio Company of Keystone Capital, on its Sale to Insight Enterprises
|
Undisclosed |
October 2025 |
Exclusive Financial Advisor to Atlantic Quantum on its Sale to Google
|
Undisclosed |
September 2025 |
Debt Capital Markets Advisor to ARMStrong Insurance Services on its Divestiture of Altus Receivables Management in Connection With a new Senior Secured Credit Facility, Inclusive of a Revolver and Term Loan With a Delayed-Draw Feature
|
Undisclosed |
September 2025 |
Exclusive Financial Advisor to ARMStrong Insurance Services, a Portfolio Company of Bharcap Partners, on the Divestiture of Altus Receivables Management to Astira Capital Partners
|
Undisclosed |
September 2025 |
Sole Placement Agent and Sole Arranger to Verita, a Portfolio Company of GCP Capital Partners, on its new Senior Secured Credit Facility, Inclusive of a Revolver and Term Loan With a Delayed-Draw Feature
|
Undisclosed |
September 2025 |
Joint Bookrunner to MBX Biosciences on its Follow-On Offering
|
$200 Million |
September 2025 |
Financial Advisor to California Earthquake Authority Regarding Policy Alternatives to Address Wildfire Risk to Electric Utilities and Recapitalize the California Wildfire Fund (SB 254)
|
$18 Billion |
September 2025 |
Joint Placement Agent to Oruka Therapeutics on its PIPE
|
$180 Million |
September 2025 |
Joint Bookrunner to Legence on its Initial Public Offering
|
$728 Million |
September 2025 |
Financial Advisor to Atlanticus Holdings on its Acquistion of Mercury Financial
|
$3.2 Billion of Gross Receivables |
September 2025 |
Joint Placement Agent to Maze Therapeutics on its Private Placement
|
$150 Million |
September 2025 |
Sole Structuring Advisor and Sole Placement Agent to Bojangles, a Portfolio Company of Durational Capital Management and The Jordan Company, on its Whole Business Securitization
|
$125 Million |
September 2025 |
Joint Bookrunning Manager to Amylyx Pharmaceuticals on its Confidentially Marketed Public Offering
|
$201 Million |
September 2025 |
Joint Bookrunner to Via Transportation on its Initial Public Offering
|
$493 Million |
September 2025 |
Joint Bookrunner to American Electric Power on its Subordinated Notes Offering
|
$2 Billion |
September 2025 |
Joint Bookrunner to Mirion Technologies on its Convertible Bond Offering
|
$375 Million |
September 2025 |
Joint Bookrunner to uniQure on its Confidentially Marketed Public Offering
|
$345 Million |
September 2025 |
Financial Advisor to SSI Strategy a Portfolio Company of Amulet Capital Partners on its Sale to Clinigen a Portfolio Company of Triton
|
Undisclosed |
September 2025 |
Sole Financial Advisor to Embark on its Strategic Investment From Parthenon Capital
|
Undisclosed |
August 2025 |
Exclusive Financial Advisor to Black Duck a Portfolio Company of Clearlake Capital and Francsico Partners on the Sale of its Services Business to UltraViolet Cyber
|
Undisclosed |
August 2025 |
Financial Advisor to Slipstream IT, a Portfolio Company of GreyLion and Denali Growth Partners, on its Financing Transaction
|
Undisclosed |
August 2025 |
Debt Capital Markets Advisor to Wipfli on its new Senior Secured Credit Facility, Inclusive of a Revolver and a Delayed-Draw Feature
|
Undisclosed |
August 2025 – Pending |
Financial Advisor to One Equity Partners on its Investment in Brown & Root
|
Undisclosed |
August 2025 |
Exclusive Financial Advisor to MicroCare, a Portfolio Company of Heartwood Partners, on its Sale to Blue Sea Capital
|
Undisclosed |
August 2025 |
Lead Left Bookrunner to Assembly Biosciences on its Underwritten Registered Direct Offering and Concurrent Private Placement
|
$175 Million |
August 2025 – Pending |
Financial Advisor to Trace3, a Portfolio Company of American Securities, on its Sale to Apollo
|
Undisclosed |
August 2025 – Pending |
Financial Advisor to Kelvion, a Portfolio Company of Triton, on its Majority Sale to Apollo
|
Undisclosed |
August 2025 – Pending |
Financial Advisor to Wipfli on its Strategic Investment From New Mountain Capital
|
Undisclosed |
August 2025 |
Financial Advisor to GovOS, a Portfolio Company of Audax Private Equity, on its Sale to Avenu Insights & Analytics, a Portfolio Company of Arlington Capital Partners
|
Undisclosed |
August 2025 |
Sole Placement Agent and Exclusive Financial Advisor to Atmosphere Data Centers on its Strategic Growth Investment From AGC Equity Partners
|
Undisclosed |
August 2025 – Pending |
Financial Advisor to Trexon, a Portfolio Company of Audax Private Equity, on its Sale to Amphenol
|
Undisclosed |
August 2025 |
Sole Private Placement Agent and Sole Lead Arranger to Slipstream IT, a Portfolio Company of GreyLion and Denali Growth Partners, on its new Senior Secured Credit Facility, Inclusive of a Revolver and Delayed-Draw Feature
|
Undisclosed |
August 2025 |
Joint Bookrunner to Compass Therapeutics on its Confidentially Marketed Public Offering
|
$138 Million |
August 2025 |
Joint Active Bookrunner to Domino's Pizza, Inc. on its Whole Business Securitization
|
$1.32 Billion |
July 2025 |
Sole Structuring Advisor and Lead Left Bookrunning Manager to SESAC, a Portfolio Company of Blackstone, on its Whole Business Securitization
|
$929 Million |
July 2025 |
Sole Structuring Advisor and Lead Left Bookrunning Manager to Jersey Mike's, a Portfolio Company of Blackstone, on its Whole Business Securitization
|
$400 Million |
July 2025 |
Joint Bookrunning Manager to Abivax SA on its Follow-On Offering
|
$747 Million |
July 2025 |
Joint Financial Advisor to Prime Data Centers on its Strategic Investment From Snowhawk and Nuveen
|
Undisclosed |
July 2025 |
Financial Advisor to Scale Computing on its Sale to Acumera, a Portfolio Company of Oaktree Capital
|
Undisclosed |
July 2025 |
Joint Active Bookrunning Manager to Larimar Therapeutics on its Confidentially Marketed Public Offering
|
$69 Million |
July 2025 |
Joint Bookrunner to ArriVent BioPharma on its Confidentially Marketed Public Offering
|
$86 Million |
July 2025 |
Financial Advisor to Progressive Roofing, a Portfolio Company of Bow River Capital, on its Sale to TopBuild
|
$810 Million |
July 2025 |
Financial Advisor to A-LIGN, a Portfolio Company of Warburg Pincus, on its Significant Strategic Investment From Hg
|
Undisclosed |
July 2025 |
Sole Private Placement Agent and Sole Arranger to DrinkPAK on its Growth Debt Financing
|
Undisclosed |
July 2025 |
Financial Advisor and Debt Capital Markets Advisor to Brigade Capital Management and Macellum Capital Management on its Acquisition of Family Dollar
|
$1.5 Billion Asset-Based Loan Facility |
July 2025 |
Joint-Lead Placement Agent to atai Life Sciences on its Private Placement
|
$50 Million |
July 2025 |
Joint Bookrunner to Cogent Biosciences on its Confidentially Marketed Public Offering
|
$230 Million |
July 2025 |
Joint Active Bookrunner to Soleno Therapeutics on its Confidentially Marketed Public Offering
|
$230 Million |
July 2025 |
Joint Bookrunner to Dyne Therapeutics on its Follow-On Offering
|
$230 Million |
June 2025 |
Exclusive Financial Advisor to Trustwave, a Portfolio Company of MC2/The Chertoff Group, on its Sale to LevelBlue
|
Undisclosed |
June 2025 |
Exclusive Financial Advisor to TechMD, a Portfolio Company of ClearLight Partners on its Sale to Integris, a Portfolio Company of OMERS
|
Undisclosed |
June 2025 |
Joint Bookrunner to Caris Life Sciences on its Initial Public Offering
|
$494 Million |
June 2025 |
Exclusive Financial Advisor to FTV Capital on its Strategic Investment in ProfitSolv, a Portfolio Company of Lightyear Capital
|
Undisclosed |
June 2025 |
Joint Bookrunner to Cidara Therapeutics on its Follow-On Offering
|
$402 Million |
June 2025 |
Financial Advisor to Verve Therapeutics on its Sale to Eli Lilly and Company
|
$1 Billion Upfront + $0.3 Billion in an Additional CVR Payment |
June 2025 |
Lead Placement Agent to atai Life Sciences on its Private Placement
|
$30 Million |
June 2025 |
Exclusive Financial Advisor to Renewa, a Portfolio Company of QIC, on its Equity Raise From La Caisse
|
$200 Million |
June 2025 |
Sole Placement Agent to Medix Infusion, a Portfolio Company of Noro-Moseley Partners and Echo Health Ventures, on its Revolving Credit Facility and Term Loan
|
Undisclosed |
June 2025 |
Joint Active Bookrunner to Kentucky Power on its Senior Secured Recovery Bonds
|
$477.75 Million |
June 2025 |
Exclusive Financial Advisor to Advent International on its Acquisition of a Significant Minority Stake in Felix Pharmaceuticals
|
$175 Million Investment |
June 2025 |
Joint Bookrunner to Rubrik on its Convertible Senior Notes Offering
|
$1.2 Billion |
June 2025 |
Sole Structuring Advisor to Dine Brands Global on its Whole Business Securitization
|
$925 Million |
June 2025 |
Financial Advisor to Elliott Davis on its Strategic Growth Investment From Flexpoint Ford
|
Undisclosed |
June 2025 |
Joint Bookrunner to Merus N.V. on its Confidentially Marketed Public Offering
|
$345 Million |
June 2025 |
Lead Financial Advisor to AVI-SPL, a Portfolio Company of Marlin Equity Partners, on its Sale to 26North
|
Undisclosed |
June 2025 |
Joint Placement Agent to ADC Therapeutics on its PIPE
|
$100 Million |
June 2025 |
Exclusive Financial and Investment Banking Advisor to FilmRise on its Sale to Oaktree Capital Management and Merger With Existing Portfolio Company Shout! Studios
|
Undisclosed |
June 2025 |
Joint Bookrunner to Forte Biosciences on its Confidentially Marketed Public Offering
|
$77 Million |
June 2025 |
Joint Bookrunner to Public Service Company of Oklahoma on its 5.45% Senior Unsecured Notes due 2036
|
$800 Million |
June 2025 |
Joint Bookrunner to BrightSpring Health Services on its Follow-On Offering
|
$304.5 Million |
May 2025 |
Financial Advisor to InterVision Systems, a Portfolio Company of MidOcean Partners, on its Sale to NWN Carousel, a Portfolio Company of American Securities
|
Undisclosed |
May 2025 |
Co-Manager to IDACORP on its Confidentially Marketed Public Offering
|
$575 Million |
May 2025 |
Exclusive Financial Advisor to Alpha Media, a Portfolio Company of Intermediate Capital Group, on its Sale to Connoisseur Media
|
Undisclosed |
May 2025 |
Sole Structuring Advisor and Sole Bookrunning Manager to National Funding on its Small Business Loan Securitization
|
$145 Million |
May 2025 |
Joint Bookrunning Manager to A&D Mortgage on its Non-QM RMBS
|
$426.7 Million |
May 2025 – Pending |
Exclusive Financial Advisor to Rite Aid on the Sale of a Majority of its Pharmacy Assets to CVS
|
Undisclosed |
May 2025 – Pending |
Exclusive Financial Advisor to Rite Aid on the Sale of its Pharmacy Assets to Walgreens, Albertsons, Kroger, Giant Eagle, Weis Markets, and Others
|
Undisclosed |
May 2025 |
Sole Structuring Advisor and Bookrunning Manager to Rapid Finance, a Portfolio Company of Rockbridge Growth Equity, on its Small Business Loan and Factored Receivables Securitization
|
$130 Million |
May 2025 |
Sole Placement Agent to APR Energy, a Portfolio Company of Fortress Investment Group, on its Asset-Based Revolving Loan
|
$150 Million |
April 2025 |
Exclusive Financial Advisor to Persimmon Homes on its Carve-out and Sale of FibreNest to BU UK Infrastructure, a Portfolio Company of Brookfield
|
£100 Million |
April 2025 |
Lead Left Bookrunner to Rezolute on its Underwritten Registered Direct Offering
|
$104 Million |
April 2025 |
Lead Placement Agent to Verastem Oncology on its Private Placement
|
$75 Million |
April 2025 |
Joint Bookrunning Manager to Edgewise Therapeutics on its Registered Direct Offering
|
$200 Million |
April 2025 |
Exclusive Financial Advisor to Hakkoda, a Portfolio Company of Tercera, on its Sale to IBM
|
Undisclosed |
April 2025 |
Financial Advisor to Lyft on its Acquisition of FREENOW From BMW and Mercedes-Benz
|
€175 Million |
April 2025 |
Exclusive Financial Advisor to Planet Farms on its Formation of an Industrial Joint Venture Dedicated to the Development of Controlled Environment Agriculture Infrastructure With Swiss Life Asset Managers
|
€200 Million |
April 2025 |
Lead Financial Advisor to RESA Power, a Portfolio Company of Investcorp, on its Sale to Kohlberg & Company
|
Undisclosed |
April 2025 |
Exclusive Financial Advisor to Stack Infrastructure, a Portfolio Company of Blue Owl Digital Infrastructure, on the Sale of its Pan-European, Highly Interconnected Colocation Data Center Business to Apollo
|
Undisclosed |
March 2025 |
Exclusive Financial Advisor to Cloud for Good, a Portfolio Company of Achieve Partners, on its Strategic Investment From Tailwind Capital
|
Undisclosed |
March 2025 |
Financial Advisor to Avenue Capital Group on its Sale of Middle River Power, an Independent Power Producer Holding ~1.9 GW of Natural Gas and Energy Storage Facilities Across California, to Partners Group
|
$2.2 Billion |
March 2025 |
Financial Advisor to Hawaiian Electric Industries on its Sale of Hamakua Holdings to Harbert Management Corporation
|
Undisclosed |
March 2025 |
Exclusive Financial Advisor to Covis Pharmaceuticals on its Sale to Azurity Pharmaceuticals, a Portfolio Company of QHP Capital
|
Undisclosed |
March 2025 |
Joint Bookrunning Manager to A&D Mortgage on its Non-QM RMBS
|
$458.9 Million |
March 2025 |
Financial Advisor to Jazz Pharmaceuticals on its Acquisition of Chimerix
|
$935 Million |
March 2025 |
Financial Advisor to Blackstone in Connection With the Strategic Minority Investment From Funds Managed by Blackstone Credit & Insurance (BXCI) in ITE Management
|
Undisclosed |
March 2025 |
Financial Advisor to Smart ERP Solutions, a Portfolio Company of Third Century, on its Sale to Mythics a Portfolio Company of One Equity Partners
|
Undisclosed |
March 2025 |
Sole Placement Agent to Surrozen on its Dual Tranche Private Placement
|
Up to $175 Million |
March 2025 |
Sales Agent to MARA Holdings on its At-the-Market Offering
|
$2 Billion |
March 2025 |
Financial Advisor to Revelstoke Capital Partners on its Significant Investment in AOM Infusion, a Portfolio Company of Ridgemont Equity Partners
|
Undisclosed |
March 2025 |
Joint Bookrunning Manager to Foundation Finance Company on its Home Improvement Consumer Receivables Securitization
|
$371.7 Million |
February 2025 |
Financial Advisor to Pritzker Private Capital on its Investment in Americhem
|
Undisclosed |
February 2025 – Pending |
Financial Advisor to CD&R on its Perpetual Convertible Preferred Equity Investment in Columbus McKinnon to Finance its Acquisition of Kito Crosby
|
$800 Million Perpetual Convertible Preferred Equity Investment and $2.7 Billion Acquisition |
February 2025 |
Exclusive Financial Advisor to Teleflex on its Acquisition of Substantially all of the Vascular Intervention Business of BIOTRONIK
|
€760 Million |
February 2025 |
Financial Advisor to DMI, a Portfolio Company of OceanSound Partners, on its Divestiture of its Commerce, Marketing & Strategy, and Digital Engineering Services Segment to Encora, a Portfolio Company of Advent and Warburg Pincus
|
Undisclosed |
February 2025 |
Financial Advisor to Vulcan Cyber on its Sale to Tenable
|
$150 Million |
February 2025 |
Financial Advisor to BigBear.ai on its Warrant Inducement and Private Placement of new Warrants
|
Undisclosed |
February 2025 |
Joint Bookrunner to Sionna Therapeutics on its Initial Public Offering
|
$219 Million |
February 2025 |
Financial Advisor to DynaGrid, a Portfolio Company of Brown Brothers Harriman, on its Sale to Macquarie
|
Undisclosed |
February 2025 |
Lead Financial Advisor to Herc Rentals on its Definitive Agreement to Acquire H&E Equipment Services
|
$5.3 Billion |
February 2025 |
Exclusive Financial Advisor to Technologent on its Significant Minority Investment by ITOCHU
|
Undisclosed |
February 2025 |
Financial Advisor to Apax Partners on its Growth Investment in CohnReznick
|
Undisclosed |
February 2025 |
Financial Advisor to Acelyrin on its Merger With Alumis
|
48% Ownership of Combined Company |
February 2025 |
Financial Advisor to Mainline Information Systems, a Portfolio Company of H.I.G. Capital, on its Acquisition of Converge Technology Solutions
|
C$1.3 Billion |
January 2025 |
Joint Bookrunner to Immunome on its Confidentially Marketed Public Offering
|
$172.5 Million |
January 2025 |
Joint Bookrunner to Maze Therapeutics on its Initial Public Offering
|
$140 Million |
January 2025 |
Financial Advisor to Rubicon Founders on its Acquisition of Horizon Infusions
|
Undisclosed |
January 2025 – Pending |
Financial Advisor to BrightSpring Health Services on its Sale of its Community Living Business to Sevita, a Portfolio Company of Centerbridge, MDP, and Vistra
|
$835 Million |
January 2025 |
Financial Advisor to Major League Baseball in Connection With Diamond Sports Group’s Chapter 11 Restructuring
|
$9 Billion of Debt |
January 2025 |
Lead Financial Advisor to Citrin Cooperman, a Portfolio Company of New Mountain Capital, on its Significant Investment From Blackstone
|
Undisclosed |
January 2025 |
Financial Advisor to EQT Partners on its Acquisition of Scale Microgrids, a Portfolio Company of Warburg Pincus
|
Undisclosed |
January 2025 |
Financial Advisor to Roark Capital Group on its Acquisition of Ground Penetrating Radar Systems, a Portfolio Company of Kohlberg & Company
|
Undisclosed |
January 2025 |
Financial Advisor to Big Lots on its Chapter 11 Restructuring and §363 Sale to Gordon Brothers and Variety Wholesalers
|
$708 Million DIP Financing and $425 Million M&A Transaction |
January 2025 |
Joint Bookrunner to uniQure on its Confidentially Marketed Public Offering
|
$75 Million |
January 2025 |
Exclusive Financial Advisor to AST, a Portfolio Company of Recognize, on its Sale to IBM
|
Undisclosed |
January 2025 |
Sole Private Placement Agent and Sole Lead Arranger to Keystone Strategy, a Portfolio Company of RLH Equity Partners, on its Growth Debt Financing
|
Undisclosed |
January 2025 |
Joint Bookrunner to Metsera on its Initial Public Offering
|
$316 Million |
January 2025 |
Exclusive Financial Advisor to Berkshire Partners on its Strategic Investment in Thrive, a Portfolio Company of Court Square
|
Undisclosed |
January 2025 |
Financial Advisor to Frontline Road Safety, a Portfolio Company of The Sterling Group, on its Sale to Bain Capital
|
Undisclosed |
January 2025 |
Financial Advisor to Soleo Health, a Portfolio Company of H.I.G. Capital, on its Sale to Court Square and WindRose Health Investors
|
Undisclosed |
January 2025 |
Exclusive Financial Advisor to AnaptysBio on its Sale of Rights to Imsidolimab to Vanda Pharmaceuticals
|
Upfront and Drug Supply Plus Potential Milestones and Royalties |
January 2025 |
Sole Structuring Advisor and Bookrunning Manager to Libertas Funding on its Small Business Receivables Securitization
|
$100 Million |
December 2024 |
Sole Private Placement Agent and Sole Lead Arranger to ATSG, a Portfolio Company of RunTide Capital, on its ABL Revolver
|
Undisclosed |
December 2024 |
Co-Manager to A&D Mortgage on its Non-QM RMBS
|
$303.9 Million |
December 2024 |
Financial Advisor to Hawaiian Electric Industries on its Sale of 90.1% of American Savings Bank to a Group of Independent Investors
|
$405 Million |
December 2024 |
Joint Bookrunner to New Amsterdam Pharma on its Follow-On Offering
|
$479 Million |
December 2024 |
Joint Bookrunner to Revolution Medicines on its Follow-On Offering
|
$863 Million |
December 2024 |
Financial Advisor to phData on its Majority Growth Recapitalization by Gryphon Investors
|
Undisclosed |
December 2024 |
Exclusive Financial Advisor to Frontline Managed Services, a Portfolio Company of BV Investment Partners, on its Sale to Broad Sky Partners
|
Undisclosed |
December 2024 |
Financial Advisor to TricorBraun on its Acquisition of the Rigid Containers Business of Veritiv
|
Undisclosed |
December 2024 |
Financial Advisor to H.I.G. Capital on its Acquisition of Quisitive
|
Undisclosed |
December 2024 |
Debt Capital Markets Advisor and Sole Placement Agent to Terram Lab on its Senior Secured Credit Facility and Subordinated Notes in Connection With its Acquisition of Trend AT and StenCo
|
Undisclosed |
December 2024 |
Exclusive Financial Advisor to Blackstone and Greater Sum Ventures on Their Preferred Equity Investment in Inhabit
|
Undisclosed |
December 2024 |
Exclusive Financial Advisor to Salem Media Group on its Comprehensive Recapitalization of Senior Secured Notes
|
$160 Million |
December 2024 |
Financial Advisor to Premier Brands Group Holdings on its Capital Structure Refinancing
|
$245 Million ABL Revolver, $20 Million FILO Term Loan, and $66 Million Sponsor Term Loan |
December 2024 |
Exclusive Financial Advisor to Patterson Companies on its Sale to Patient Square Capital
|
$4.1 Billion |
November 2024 |
Financial Advisor to CDW on its Acquisition of Mission Cloud, a Portfolio Company of Great Hill Partners
|
Undisclosed |
November 2024 |
Financial Advisor to Veritas, a Portfolio Company of Carlyle, on its Comprehensive Recapitalization and the Merger of its Data Protection Business With Cohesity
|
$7 Billion M&A Transaction and $4.2 Billion Comprehensive Recapitalization Transaction |
December 2024 |
Sole Structuring Advisor and Lead Left Bookrunning Manager to Jersey Mike's on its Whole Business Securitization
|
$850 Million |
November 2024 |
Lead Financial Advisor to Trademark Cosmetics, a Portfolio Company of TruArc Partners, on the Execution of its Strategic Acquisition of DMI Personal Care
|
Undisclosed |
November 2024 |
Lead Financial Advisor to Jersey Mike's on its Majority Sale to Blackstone
|
$8 Billion |
November 2024 |
Financial Advisor to Qlik, a Portfolio Company of Thoma Bravo, in Connection With a Significant Minority Investment by ADIA
|
Undisclosed |
November 2024 |
Joint Bookrunning Manager to OneStream, a Portfolio Company of KKR, on its Follow-On Offering
|
$465 Million |
November 2024 |
Joint Bookrunner to MARA Holdings on its Convertible Senior Notes Offering
|
$1 Billion |
November 2024 |
Co-Manager to PG&E Corporation on its Junior Subordinated Notes Offering
|
$500 Million |
November 2024 |
Sole Structuring Advisor and Sole Active Bookrunning Manager to Cloud Capital on its Data Center ABS
|
$1.325 Billion |
November 2024 |
Joint Bookrunner to Spyre Therapeutics on its Follow-On Offering
|
$230 Million |
November 2024 |
Financial Advisor to Fortress Investment Group on its Purchase of 850 MW of Power Generation Assets From APR Energy to be Operated Through an Asset Management Agreement With Duos Energy
|
Undisclosed |
November 2024 |
Sales Agent to Chesapeake Utilities Corporation on its At-the-Market Offering
|
$100 Million |
November 2024 |
Capital Markets Advisor to Forte Biosciences on its PIPE
|
$53 Million |
October 2024 |
Sole Structuring Advisor and Sole Bookrunning Manager to Bojangles, a Portfolio Company of Durational Capital Management and TJC, on its Whole Business Securitization
|
$625 Million |